PORCN and B-cell chronic lymphocytic leukemia: Another reasonable possibility to target WNT pathways in CLL is by treatment with PORCN inhibitors, since leukemic cells overexpress several WNT ligands that might be crucial for the pathophysiology of CLL [31,33,34].